Mandate

Vinge has advised Byggfakta in connection with its listing on Nasdaq Stockholm

The first day of trading on Nasdaq Stockholm large cap was 15 October 2021. The offer price was SEK 75 per share, equivalent to a market value for the Byggfakta Group of approximately SEK 16.4 billion. The offer covers 64,483,197 shares together with an oversubscription option to a total value of approximately SEK 5.5 billion.

Byggfakta Group, with its registered office in Ljusdal, Sweden, and dating back to 1936, is a leading digital platform which offers solutions which match actors in the building industry’s value chain, maximizes sales and improves efficiency for its customers.

Vinge’s team primarily consisted of Anders Strid, Rikard Lindahl, Edin Agic, Lina André, Linus Adolfsson, David Bokliden, Adrian Filipovic and Jacob Benzow (Capital Markets and Public M&A), Magnus Pauli (M&A), Albert Wållgren, Linn Adelwald, Ludvig Wettergren (Banking and Finance), Maria Schultzberg, Victor Ericsson and Emelie Svanberg (Tax), Anna-Maria Lagerqvist Gahm, Anna Högsten and Stina Karinsdotter (IP/IT), Rebecka Hansson (Employment) and Viktoria Owetz Leyva and Nathalie Hughes (VDR).

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025